Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Development and characterisation of recombinant LSDV-vectored dual vaccines against bovine leukaemia virus and lumpy skin disease virus
Bovine leukaemia virus (BLV) and lumpy skin disease virus (LSDV) are endemic to Africa and cause significant economic losses to the beef and dairy industries. Vaccines are the most cost-effective and efficient way to prevent infection and outbreaks. Currently, there is no commercially available vacc...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Pathology
2020
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Development and characterisation of recombinant LSDV-vectored dual vaccines against bovine leukaemia virus and lumpy skin disease virus
- An evaluation of the vaccine-vector potential of thymidine kinase-disrupted recombinants of lumpy skin disease virus (South African vaccine)
- Determination and analysis of the complete genome sequences of a vaccine strain and field isolate of Lumpy Skin Disease Virus (LSDV)
- Improvement of the Capripoxvirus, lumpy skin disease virus for use as a vaccine vector
- An investigation into the Use of Lumpy Skin Disease Virus as a Vaccine Vector for a Potential HIV-1 vaccine
- The development of recombinant lumpy skin disease virus vaccines for foot-and-mouth disease and rift valley fever
- Comparison of the two lumpy skin disease virus vaccines, Neethling and Herbivac, and construction of a recombinant Herbivac-Rift Valley fever virus vaccine